Aspirin prevents preeclampsia and complications

This meta-analysis shows that the use of aspirin in pregnant women predisposed to preeclampsia significantly reduces the rates of preeclampsia and perinatal death, without evidence of harm. A recent Cochrane review showed similar results.¹It is reasonable to recommend low-dose aspirin therapy to women who have 1 or more risk factors for preeclampsia.

This meta-analysis shows that the use of aspirin in pregnant women predisposed to preeclampsia significantly reduces the rates of preeclampsia and perinatal death, without evidence of harm. A recent Cochrane review showed similar results.¹It is reasonable to recommend low-dose aspirin therapy to women who have 1 or more risk factors for preeclampsia.

This meta-analysis shows that the use of aspirin in pregnant women predisposed to preeclampsia significantly reduces the rates of preeclampsia and perinatal death, without evidence of harm. A recent Cochrane review showed similar results.¹It is reasonable to recommend low-dose aspirin therapy to women who have 1 or more risk factors for preeclampsia.